论文部分内容阅读
目的:探讨小儿急性胰腺炎合并感染的治疗策略,为小儿急性胰腺炎合并感染的临床治疗提供有效依据。方法:选取2010年7月至2015年7月收治的40例急性胰腺炎合并感染患儿作为研究对象,将其随机分为对照组和观察组,每组各20例,对照组采用生长抑素及奥美拉唑治疗,观察组在对照组治疗的基础上加用中药清胰II号治疗,对比两组的临床疗效。结果:对照组治疗总有效率为55.0%;观察组治疗总有效率为90.0%,观察组治疗总有效率较对照组明显提高(P<0.05)。与对照组相比,观察组的血、尿淀粉酶恢复正常正常水平时间、白细胞恢复正常水平时间均明显缩短(P<0.05)。结论:在常规治疗的基础上,加用中药清胰II号治疗急性胰腺炎合并感染具有良好效果。
Objective: To investigate the treatment strategy of children with acute pancreatitis complicated infection and provide an effective basis for the clinical treatment of children with acute pancreatitis complicated with infection. Methods: Forty patients with acute pancreatitis complicated with infection from July 2010 to July 2015 were selected as the research object, which were randomly divided into control group and observation group with 20 cases in each group. The control group was treated with somatostatin And omeprazole treatment, the observation group in the control group based on the treatment of traditional Chinese medicine Qingyin II treatment, the clinical efficacy of the two groups were compared. Results: The total effective rate of the control group was 55.0%. The total effective rate of the observation group was 90.0%. The total effective rate of the observation group was significantly higher than that of the control group (P <0.05). Compared with the control group, the observation group’s serum and urine amylase returned to normal and normal levels, and the leukocyte recovery time was significantly shorter (P <0.05). Conclusion: On the basis of routine treatment, the addition of Qingyin II in the treatment of acute pancreatitis complicated with infection has a good effect.